Silexion Therapeutics Corp (SLXN) Operating cash flow 2023–2025
Silexion Therapeutics Corp (SLXN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.8MFY2025 · since FY2023: -$4.5M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | -28.9% |
| FY2024 | -$8.4M | -85.4% |
| FY2023 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLXN financial trends
SLXN RevenueSLXN Net incomeSLXN Net marginSLXN Gross profitSLXN Gross marginSLXN Operating incomeSLXN Operating marginSLXN Free cash flowSLXN Capital expendituresSLXN Return on equitySLXN Stock buybacksSLXN Dividends paidSLXN Total assetsSLXN Total liabilitiesSLXN Shareholders’ equitySLXN overview →